Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C105 - Mild Cognitive Impairment/Subjective Cognitive Impairment

Monday 04/24/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Ronald C. Petersen, PhD, MD, FAAN
Aging, Dementia, Cognitive, and Behavioral Neurology
Participants will understand the construct of mild cognitive impairment, identify criteria for the diagnosis of MCI, use MCI as a clinical syndrome, differentiate underlying causes of MCI for treatment, develop a program for evaluating patients for pharmacotherapy, and evaluate the longitudinal outcome of patients with MCI.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student, Business Administrator
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM EST Introduction Overview of MCI
Ronald C. Petersen, PhD, MD, FAAN
04:00 PM - 04:30 PM EST Speaker Atypical Presentations of MCI
Oscar L. Lopez, MD, FAAN
04:30 PM - 05:00 PM EST Speaker Treatment of MCI
David J. Gill, MD, FAAN
05:00 PM - 05:30 PM EST Speaker Case Studies
Ronald C. Petersen, PhD, MD, FAAN, David J. Gill, MD, FAAN, Oscar L. Lopez, MD, FAAN
Faculty Disclosures
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
David J. Gill, MD, FAAN Dr. Gill has nothing to disclose.
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck.